About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Adar
adenosine deaminase, RNA-specific
MGI:1889575
54 phenotypes from 11 alleles in 12 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Adarem1Stsn/Adarem1Stsn
involves: C57BL/6J
normal embryo phenotype J:308678
normal growth/size/body region phenotype J:308678
normal mortality/aging J:308678
Adarem1Stsn/Adartm1.1Phs
Meox2tm1(cre)Sor/Meox2+
involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J
decreased body size J:308678
lethality, complete penetrance J:308678
Adarem1Stsn/Adartm1Olds
involves: 129S/SvEv * C57BL/6J
abnormal homeostasis J:308678
abnormal liver morphology J:308678
abnormal renal glomerulus morphology J:308678
abnormal spleen morphology J:308678
decreased body size J:308678
decreased circulating serum albumin level J:308678
expanded mesangial matrix J:308678
increased circulating alkaline phosphatase level J:308678
lethality, complete penetrance J:308678
Adarem2Qwan/Adarem2Qwan
Not Specified
normal growth/size/body region phenotype J:325221
normal immune system phenotype J:325221
Adarem3Qwan/Adarem3Qwan
Not Specified
abnormal chemokine level J:325221
decreased body size J:325221
decreased body weight J:325221
normal immune system phenotype J:325221
increased circulating interleukin-1 level J:325221
increased circulating interleukin-6 level J:325221
increased circulating interleukin-17 level J:325221
increased CXCL10 level J:325221
Adartm1.1Knk/Adar+
involves: 129S1/Sv * 129X1/SvJ
normal mortality/aging J:87714
Adartm1.1Knk/Adartm1.1Knk
involves: 129S1/Sv * 129X1/SvJ
abnormal apoptosis J:87714
embryonic lethality during organogenesis, complete penetrance J:87714
normal hematopoietic system phenotype J:87714
increased embryonic tissue cell apoptosis J:87714
increased hepatocyte apoptosis J:87714
increased sensitivity to induced cell death J:87714
internal hemorrhage J:87714
pale yolk sac J:87714
Adartm1.1Phs/Adartm2Phs
Tg(Mx1-cre)1Cgn/?
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
abnormal definitive hematopoiesis J:142338
liver hypoplasia J:142338
postnatal lethality, complete penetrance J:142338
Adartm1.1Phs/Adartm2Phs
Tg(Tal1-cre/ERT)42-056Jrg/?
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
abnormal hematopoietic stem cell morphology J:142338
decreased bone marrow cell number J:142338
Adartm1b(EUCOMM)Wtsi/Adar+
B6N(Cg)-Adartm1b(EUCOMM)Wtsi/J
decreased circulating glucose level J:211773
Adartm1b(EUCOMM)Wtsi/Adartm1b(EUCOMM)Wtsi
B6N(Cg)-Adartm1b(EUCOMM)Wtsi/J
abnormal embryo size J:211773
abnormal neural tube closure J:211773
abnormal placenta size J:211773
pale yolk sac J:211773
pallor J:211773
preweaning lethality, complete penetrance J:211773
Adartm1Knk/Adartm1Knk
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA
abnormal circulating enzyme level J:87714
abnormal liver morphology J:87714
decreased body size J:87714
normal hematopoietic system phenotype J:87714
hyperglycemia J:87714
increased circulating alanine transaminase level J:87714
increased circulating alkaline phosphatase level J:87714
increased circulating aspartate transaminase level J:87714
increased circulating lactate dehydrogenase level J:87714
increased hepatocyte apoptosis J:87714
Adartm1Olds/Adartm1Olds
involves: 129S/SvEv * C57BL/6J
abnormal cell physiology J:169014
embryonic lethality during organogenesis, complete penetrance J:169014
increased susceptibility to Orthomyxoviridae infection J:169014
increased susceptibility to Paramyxoviridae infection J:169014
Adartm1Phs/Adartm1Phs
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
abnormal liver development J:87715
absent common myeloid progenitor cells J:87715
embryonic growth retardation J:87715
embryonic lethality during organogenesis, complete penetrance J:87715
impaired hematopoiesis J:87715
small liver J:87715
Adartm1Phs/Adartm1Phs
involves: 129S1/Sv * 129X1/SvJ * NMRI
abnormal liver development J:87715
absent common myeloid progenitor cells J:87715
embryonic growth retardation J:87715
embryonic lethality during organogenesis, complete penetrance J:87715
impaired hematopoiesis J:87715
small liver J:87715
Adartm2Knk/Adar+
chimera involves: 129S1/Sv * 129X1/SvJ * FVB/N
abnormal embryonic erythropoiesis J:65981
abnormal liver development J:65981
embryonic lethality during organogenesis, complete penetrance J:65981
Adartm2Phs/Adartm2Phs
B6.Cg-Adartm2Phs
abnormal circulating interferon-beta level J:142338
abnormal hematopoietic stem cell morphology J:142338
increased circulating interferon-alpha level J:142338
Adartm2Phs/Adartm2Phs
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
abnormal liver development J:87715
absent common myeloid progenitor cells J:87715
embryonic growth retardation J:87715
embryonic lethality during organogenesis, complete penetrance J:87715
impaired hematopoiesis J:87715
small liver J:87715
Adartm2Phs/Adartm2Phs
involves: 129S1/Sv * 129X1/SvJ * NMRI
abnormal liver development J:87715
absent common myeloid progenitor cells J:87715
embryonic growth retardation J:87715
embryonic lethality during organogenesis, complete penetrance J:87715
impaired hematopoiesis J:87715
small liver J:87715

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory